Most men see their true after results by about six months
Their contribution is scale and consistency
Commonly used in research, it is believed to support tissue repair and recovery
(Pop Busui et al., 2026) What this changes for how I think in clinic: if a patient has type 2 diabetes plus heart failure, especially preserved ejection fraction, oral semaglutide is moving closer to the center of the risk reduction conversation alongside the rest of guideline directed therapy
But new research offers hope: two widely used diabetes medications, semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), may do more than just manage blood sugar
Findings In this economic evaluation of 30 million cumulative Medicare beneficiaries identified as eligible for new GLP-1RAs for obesity treatment over the next 10 years, Medicares total projected costs for drug coverage of the GLP-1RAs were $65.9 billion